Form 4: Hims & Hers CFO Oluyemi Okupe Executes Pre-Planned Stock Option Exercise and Sale

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, executed a pre-planned transaction involving the exercise of stock options and the subsequent sale of Class A Common Stock on July 7, 2025.

Summary

• Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, engaged in a pre-planned transaction on July 7, 2025.
• The transaction involved the exercise of stock options to acquire 6,437 shares of Class A Common Stock at an exercise price of $5.01 per share.
• Concurrently, 11,581 shares of Class A Common Stock were sold at an average weighted price of $46.6711 per share, with prices ranging from $46.52 to $47.02.
• Following these transactions, Oluyemi Okupe beneficially owns 58,078 shares of Class A Common Stock directly and 380,533 stock options.
• Both the option exercise and the stock sale were conducted under a Rule 10b5-1 trading plan adopted on May 31, 2024.

Sentiment

Score: 5

Explanation: Neutral. The transactions are routine insider disclosures under a pre-planned Rule 10b5-1 trading plan, which reduces the interpretative significance of the sale. It's an expected part of executive compensation and liquidity management.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-scheduled, non-discretionary sales, which can mitigate concerns about insider selling based on non-public information.
• The CFO continues to hold a significant number of stock options (380,533) and direct shares (58,078), indicating continued alignment with shareholder interests.

Negatives

• The sale of 11,581 shares by a key executive, even if pre-planned, reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale by a CFO, even if pre-planned, slightly reduces insider ownership, which could be viewed neutrally or with slight caution, though the 10b5-1 plan mitigates negative interpretations. The exercise of options at a low price and sale at a higher price indicates the executive realizing value from their compensation.

Next Steps

• The remaining stock options will continue to vest according to the established schedule, with 25% vesting on the 12-month anniversary of January 24, 2022, and the balance vesting in 36 successive equal monthly installments thereafter, subject to continuous service.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Oluyemi Okupe, Chief Financial Officer, Equity Transaction